Assessing Neurovascular Involvement in Musculoskeletal Tumors
Author Information
Author(s): DAVID M. PANICEK, SUSAN HILTON, LAWRENCE H. SCHWARTZ
Primary Institution: Memorial Sloan-Kettering Cancer Center
Hypothesis
How can imaging techniques accurately assess neurovascular involvement by malignant musculoskeletal tumors?
Conclusion
Imaging techniques have limitations in accurately assessing neurovascular involvement by sarcomas due to the small size of structures and low prevalence of involvement.
Supporting Evidence
- The prevalence of neurovascular involvement was found to be 3.3% for primary bone tumors and 4.5% for primary soft tissue tumors.
- The positive predictive value of CT and MRI for neurovascular involvement was only 6-27%, with a negative predictive value of 92-99%.
- Imaging techniques struggle to differentiate between tumor contact and actual invasion due to the small size of nerves and vessels.
Takeaway
Doctors use special pictures to see if tumors are touching important nerves and blood vessels, but it's hard to tell for sure because these structures are small.
Methodology
The study involved comparing CT and MRI imaging techniques in assessing neurovascular involvement in primary bone and soft tissue tumors.
Limitations
The low prevalence of neurovascular involvement affects the predictive values of imaging tests.
Participant Demographics
The study included 183 primary bone tumors and 133 primary soft tissue tumors.
Want to read the original?
Access the complete publication on the publisher's website